கோட்டக் இந்தியா ஈக் கான்ட்ரா News Today : Breaking News, Live Updates & Top Stories | Vimarsana

SBI Contra: Time to take home some gains
Yoganand D
BL Research Bureau |
Updated on
March 13, 2021
Fund has returned 70% in past year, but its defensive preference could lead to underperformance
Investors holding the units of SBI Contra Fund can book profits as the fund has made 70 per cent gains in the last one-year period.
Even after such superlative performance which puts the veteran scheme among the chart-toppers in fund categories such as IT, small-cap, mid-cap and infra the scheme lags the benchmark (S&P BSE 500 TRI) in three- and five-year periods.
The economy is recovering after two quarters of sharp negative growth and the GDP has showed marginal positive up-tick in the third quarter. However, the fund continues to be predominantly geared towards defensives, which increases the probability of underperformance if strong economic growth continues, riding high on cyclicals. ....

Axis Bank , Sun Pharmaceutical Industries , Contra Fund , Kotak India , Invesco India Contra , Sbi Contra , Kotak India Eq Contra , Contrairian Investment Strategy , அச்சு வங்கி , சூரியன் மருந்து தொழில்கள் , கான்ட்ரா நிதி , கோட்டக் இந்தியா , இன்வெஸ்கோ இந்தியா கான்ட்ரா , ஸ்பி கான்ட்ரா , கோட்டக் இந்தியா ஈக் கான்ட்ரா ,